The first developed technology platform with various application scenarios, including infectious disease, fertility, DOA, etc.
50+ kinds of reagents and five high-performance devices, focusing on detecting cardiovascular disease, inflammation, kidney injury, sex hormones, thyroid function, diabetes, tumor, and others.
Wondfo optical blood coagulation analyzer is the first one in the world that can test PT, APTT, TT, FIB, and ACT simultaneously.
Our Blood Gas Analyzer BGA-102 can produce the result in 30s. Its advantages of portability, easy operation, durability, and high performance make it ideal for clinics, laboratories, and hospitals.
Wondfo Dry Chemistry Analyzer can test 16 items and provide the result within 2 minutes, ideal for the detection of cardiac markers, kidney function, liver function, pancreatitis, etc.
Ready-to-use lyophilized RT-PCR Reagent；
Gold Standard for COVID-19 Diagnosis
Wondfo Launches HIV Self-Testing Campaign in Uganda
November 15,2024 (Edit) Wondfo
In an impactful collaboration with Uganda’s Ministry of Health and Kampala Capital City Authority (KCCA), Wondfo Biotech has launched a pioneering initiative to promote HIV self-testing among bodaboda riders and market vendors in Uganda. These groups, often underserved and at higher risk for HIV, are central to the campaign's focus on increasing early diagnosis and reducing transmission rates.
The Wondfo HIV Self-Test is a user-friendly, single-use kit that provides results from a finger-stick blood sample in just 15 minutes, enabling individuals to check their HIV status privately and conveniently. This accessibility encourages regular testing, especially among men who may face some barriers in traditional healthcare settings.
To maximize reach and impact, the campaign takes self-testing kits, counseling services, and educational resources directly to urban communities. Audiovisual trucks display HIV prevention messages to raise awareness, while on-the-ground teams distribute free HIV self-test kits and offer counseling support.
Dr. Diana Atwine, Permanent Secretary at Uganda’s Ministry of Health, highlighted the importance of Wondfo’s support, noting, “This collaboration will be instrumental in breaking down barriers to HIV testing and treatment, bringing healthcare closer to vulnerable populations and bridging critical healthcare gaps.”
Racing for Life, Wondfo will continue to advancing health outcomes in underserved communities through innovative, accessible, and reliable diagnostic solutions.
The first developed technology platform with various application scenarios, including infectious disease, fertility, DOA, etc.
50+ kinds of reagents and five high-performance devices, focusing on detecting cardiovascular disease, inflammation, kidney injury, sex hormones, thyroid function, diabetes, tumor, and others.
Single-dose Chemiluminescense Immunoassay Platform
Wondfo optical blood coagulation analyzer is the first one in the world that can test PT, APTT, TT, FIB, and ACT simultaneously.
Our Blood Gas Analyzer BGA-102 can produce the result in 30s. Its advantages of portability, easy operation, durability, and high performance make it ideal for clinics, laboratories, and hospitals.
Wondfo Dry Chemistry Analyzer can test 16 items and provide the result within 2 minutes, ideal for the detection of cardiac markers, kidney function, liver function, pancreatitis, etc.
Ready-to-use lyophilized RT-PCR Reagent；
Wondfo PA-3600 IHC Staining System
Advanced rapid diagnostic test with WHO prequalification for infectious disease
The Future Intelligent Medical Assistant to Healthcare
Fight against the pandemic through continuous innovation
